High materiality7/10
Iovance Biotherapeutics price target raised to $20 from $9 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update raises IOVA's target from $9 to $20; current price $14.06.
- Target raised to $20; price $14.06.
Key facts
- 01
Target: $20
- 02
Posted price: $14.06
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Joseph Pantginis
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.